- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
2014 a Bad Year for Public Health; 2015 Unlikely to Differ
The Associated Press reported that 2014 was a “black-eye year for public health” due to a variety of mishaps, including “vital vaccines” failing to work and the worst-ever Ebola epidemic.
The Associated Press reported that 2014 was a “black-eye year for public health” due to a variety of mishaps, including “vital vaccines” failing to work and the worst-ever Ebola epidemic. And while there were some success stories, some believe the future doesn’t look particularly bright.
As quoted in the market news:
Infectious diseases are a continuing threat, and no one should think of 2014 as an aberration, said Michael Osterholm, a University of Minnesota infectious disease expert.
‘I think what we really hit is a new normal,’ he said.
Indeed, it could get worse. Osterholm noted that Ebola and MERS barely touched the U.S. this year, and worrisome forms of influenza in Asia and elsewhere may be on the horizon. Arrivals of people from overseas — and whatever germs they’re carrying — are forecast to keep growing. And adding to the threat of new bugs is the revived menace from old ones, as once-treatable germs are increasingly becoming resistant to antibiotics, experts said.
Click here to read the full report from the Associated Press.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.